Susanne Tries

Title: Susanne Tries: Innovator in Pharmaceutical Chemistry

Introduction

Susanne Tries is a notable inventor based in Ehingen, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on fused pyrrole compounds and their applications in medicine. With a total of two patents to her name, her research focuses on developing compounds that can address various health disorders.

Latest Patents

Tries' latest patents include "Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof." This invention relates to fused pyrrole compounds characterized by specific radicals, particularly those with a 4-sulphur-substituted phenyl group. These compounds exhibit selective inhibitory action on isoenzyme-2 of prostaglandin H synthase (COX-2) and are aimed at treating rheumatic disorders. Another significant patent is for "4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy." This invention focuses on derivatives that have immunomodulating effects and can be utilized for treating immune system disturbances.

Career Highlights

Susanne Tries is currently employed at Merckle GmbH, where she continues her research and development in pharmaceutical innovations. Her work has been instrumental in advancing the understanding and application of pyrrole compounds in medical treatments.

Collaborations

Throughout her career, Tries has collaborated with esteemed colleagues such as Hans-Guenter Striegel and Stefan Laufer. These partnerships have enhanced her research efforts and contributed to the successful development of her patented compounds.

Conclusion

Susanne Tries stands out as a pioneering inventor in the pharmaceutical industry, with her innovative work on pyrrole compounds paving the way for new treatments. Her contributions are vital in addressing health challenges and improving patient care.